Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
31.98
-1.75 (-5.19%)
At close: Mar 5, 2026, 4:00 PM EST
31.93
-0.05 (-0.16%)
After-hours: Mar 5, 2026, 4:10 PM EST
Immunocore Holdings Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Immunocore Holdings stock have an average target of 64.7, with a low estimate of 33 and a high estimate of 100. The average target predicts an increase of 102.31% from the current stock price of 31.98.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Immunocore Holdings stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $71 → $75 | Strong Buy | Maintains | $71 → $75 | +134.52% | Feb 26, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +212.70% | Feb 4, 2026 |
| UBS | UBS | Strong Sell → Strong Buy Initiates $24 → $55 | Strong Sell → Strong Buy | Initiates | $24 → $55 | +71.98% | Jan 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $34 → $36 | Hold | Maintains | $34 → $36 | +12.57% | Nov 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $60 | Buy | Initiates | $60 | +87.62% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
457.57M
from 400.02M
Increased by 14.39%
Revenue Next Year
495.04M
from 457.57M
Increased by 8.19%
EPS This Year
-1.08
from -0.71
EPS Next Year
-1.26
from -1.08
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 513.5M | 628.5M | |||
| Avg | 457.6M | 495.0M | |||
| Low | 423.2M | 338.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 28.4% | 37.4% | |||
| Avg | 14.4% | 8.2% | |||
| Low | 5.8% | -26.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.34 | 0.98 | |||
| Avg | -1.08 | -1.26 | |||
| Low | -2.31 | -3.83 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.